Pharmather to seek FDA guidance for ketamine study in Parkinson’s
Pharmather is planning to meet with the U.S. Food and Drug Administration (FDA) in hopes of reaching an agreement…
Articles by Lila Levinson, PhD
Patients pick Medtronic adaptive DBS over traditional technology
Parkinson’s disease patients in a clinical trial preferred Medtronic’s BrainSense adaptive deep brain stimulation (aDBS) technology — which…
Oncodesign joins MJFF LRRK2 development collaboration
Oncodesign Precision Medicine (OPM) joined a Michael J. Fox Foundation (MJFF) program to develop potential therapies that target the…
First trial group gets commercial formulation of Parkinson’s therapy
In a trial milestone, participants in the third patient group of the ASPIRO Phase 1/2a study (NCT06344026) are now…
Parkinson’s gene therapy AB-1005 trial moves forward in Europe
The first European patients in Askbio‘s Phase 2 clinical trial of AB-1005, an experimental gene therapy for Parkinson’s…
Scientists may have found way to prevent constipation in Parkinson’s
Interactions between receptors for ghrelin, the so-called hunger hormone, and the chemical signaling molecule dopamine may go awry in…
Moving Day walks to raise funds for Parkinson’s research
The Parkinson’s Foundation will organize events in 20 U.S. cities this fall as part of Moving Day, a…
MJFF funds collaboration to identify toxic proteins on PET scans
The Michael J. Fox Foundation (MJFF) is funding work to develop imaging technology for monitoring toxic proteins in…
Experts push for ways to expand Parkinson’s specialist care
A new study suggests that simple, targeted strategies, from using telehealth to standardizing patient referrals, could help more people with…
Study says metabolic abnormalities may be risk factor for Parkinson’s
People with metabolic syndrome, a cluster of metabolism-related abnormalities — like a larger waist circumference, high blood sugar, and abnormal…